| INMED PHARMACEUTICALS |
| Kanada |
| Gesundheit |
| CA4576377002 / A40UCN |
| MWG (Frankfurt) / INM (NASDAQ) |
| FRA:MWG, ETR:MWG, MWG:GR, NASDAQ:INM |
| - |
| https://www.inmedpharma.c.. |
|
InMed Pharmaceuticals Inc., a clinical stage pharm..
>Volltext.. |
| 3.99 Mio. EUR |
| -3.45 Mio. EUR |
| 4.14 Mio. EUR |
| -6.37 Mio. EUR |
| -7.09 Mio. EUR |
| -5.96 EUR |
| 0.55 Mio. EUR |
| 8.05 Mio. EUR |
| -6.57 Mio. EUR |
| 6.03 |
| -8.22% |
| -14.3% |
| - |
| - |
| - |
| - |
| INMED |
| 18.11.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|